Comparison · NCT00567268-2d560bc4
Presence of Non-Drug Therapy vs Absence of Non-Drug Therapy: Number of Participants Who Responded to Treatment With Gabapentin by Presence or Absence of Non-Drug Therapy
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Presence of Non-Drug Therapy vs Absence of Non-Drug Therapy: Number of Participants Who Responded to Treatment With Gabapentin by Presence or Absence of Non-Drug Therapy. Trial comparisons, record NCT00567268-2d560bc4. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00567268-2d560bc4
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.756 | 0.613 | 0.858 | wilson | |
| Risk in group 2 | 0.605 | 0.574 | 0.635 | wilson | |
| Risk difference, group 1 minus group 2 | 0.151 | 0.00517 | 0.257 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 1.25 | 1.05 | 1.49 | log | |
| Odds ratio, group 1 over group 2 | 2.02 | 1.01 | 4.03 | log | |
| Number needed to treat, for one more participant with the outcome on Presence of Non-Drug Therapy than on Absence of Non-Drug Therapy | 6.64 | 3.89 | 193 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Presence of Non-Drug Therapy | Participants with non-drug therapy who responded to treatment with gabapentin | 34 | 45 | OG000 |
| Group 2 | Absence of Non-Drug Therapy | Participants without non-drug therapy who responded to treatment with gabapentin | 605 | 1,000 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- OTHER_PRE_SPECIFIED
- Title
- Number of Participants Who Responded to Treatment With Gabapentin by Presence or Absence of Non-Drug Therapy
- Description
Participants who responded to the treatment with gabapentin were counted by the presence or absence of non-drug therapy to assess whether the non-drug therapy was a factor affecting the treatment efficacy.
- Time frame
- 12 weeks
- Population
The efficacy analysis population comprised of the participants who had at least one post-baseline efficacy evaluation for the clinical efficacy and seizure frequency in the safety analysis population. Participants who had diseases not eligible for the survey were excluded from the efficacy analysis population.
Source ClinicalTrials.gov
Trial
- Title
- Drug Use Investigation Of Gabapentin
- NCT number
- NCT00567268
- Phases
- Conditions
- Epilepsies, Partial
- Interventions
- Gabapentin
- Lead sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Results first posted
- 2015-05-12
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00567268?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00567268-2d560bc4